Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.

Nasdaq · CIK 0001823239
Filer categoryAccelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts352

Identity from submissions API

NameMARAVAI LIFESCIENCES HOLDINGS, INC.
CIK0001823239
TickersMRVI
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858) 546-0004
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
10770 WATERIDGE CIRCLE SUITE 200
SAN DIEGO
CA
92121
CA
Mailing address
10770 WATERIDGE CIRCLE SUITE 200
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

426 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 4 FORM 4 0001380632-26-000012 5649
2026-11-05 10-Q 10-Q 0001823239-26-000068 001-39725 261527066 34 8742096 1 1
2026-11-04 8-K 8-K 9.01 0001823239-26-000065 001-39725 261521969 34 384701 1 1
2026-11-02 4 FORM 4 0001600301-26-000010 6131
2026-10-09 4 FORM 4 0001380632-26-000010 5649
2026-10-01 4 FORM 4 0001600301-26-000008 4950
2026-09-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-112023 005-92094 261425114 34 15230
2026-09-09 4 FORM 4 0001380632-26-000008 5649
2026-09-01 4 FORM 4 0001600301-26-000006 4950
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001398344-26-014381 005-92094 261274063 34 15974
2026-08-11 4 FORM 4 0001380632-26-000006 5649
2026-08-07 10-Q 10-Q 0001823239-26-000059 001-39725 261253868 34 7323361 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001823239-26-000056 001-39725 261248863 34 385557 1 1
2026-08-03 4 FORM 4 0001600301-26-000004 4950
2026-07-10 4 FORM 4 0001380632-26-000004 5649
2026-07-01 4 FORM 4 0001600301-26-000002 4951
2026-06-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-078987 005-92094 261137450 34 16029
2026-06-23 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-076907 005-92094 261112597 34 15655
2026-06-10 4 FORM 4 0001380632-26-000002 5650
2026-06-10 4 FORM 4 0001832579-26-000007 6278
2026-06-10 4 FORM 4 0001251299-26-000005 6965
2026-06-10 144 xsl144X01/primary_doc.xml 0001959173-26-004507 001-39725 261078832 33 5029
2026-06-09 144 xsl144X01/primary_doc.xml 0001959173-26-004463 001-39725 261074946 33 5972
2026-06-03 8-K 8-K 1.01,1.02,2.03,7.01,9.01 0001823239-26-000049 001-39725 261059028 34 2890534 1 1
2026-05-29 8-K 8-K 5.07 0001823239-26-000046 001-39725 261044755 34 155231 1 1
2026-05-28 4/A FORM 4/A 0001251299-26-000003 6040
2026-05-28 4 FORM 4 0001829810-26-000001 5550
2026-05-28 4 FORM 4 0001833453-26-000004 5019
2026-05-28 4 FORM 4 0001262930-26-000001 5620
2026-05-28 4 FORM 4 0001210525-26-000001 5040
2026-05-28 4 FORM 4 0001251299-26-000001 5776
2026-05-28 4 FORM 4 0001829753-26-000001 5566
2026-05-28 4 FORM 4 0001403373-26-000005 5035
2026-05-22 4 FORM 4 0001684273-26-000005 5299
2026-05-22 4 FORM 4 0001832579-26-000005 5134
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-002470 005-92094 26982584 34 10770
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001398344-26-009186 005-92094 26979367 34 15935
2026-05-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-059524 005-92094 26970063 34 15896
2026-05-08 10-Q 10-Q 0001823239-26-000024 001-39725 26958911 34 6047174 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001823239-26-000022 001-39725 26953121 34 320336 1 1
2026-04-28 DEFA14A DEFA14A 0001823239-26-000016 001-39725 26902705 34 3940188 1 1
2026-04-24 ARS ARS 0001193125-26-177478 001-39725 26895017 34 1577847
2026-04-24 DEF 14A DEF 14A 0001823239-26-000014 001-39725 26894702 34 2224193
2026-03-17 4 FORM 4 0001684273-26-000003 4926
2026-03-17 4 FORM 4 0001832579-26-000003 4764
2026-02-26 10-K 10-K 0001823239-26-000011 001-39725 26687838 34 14260368 1 1
2026-02-25 8-K 8-K 2.02,9.01 0001823239-26-000005 001-39725 26678420 34 405132 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001031 005-92094 26637827 34 10604
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001398344-26-003117 005-92094 26633383 34 15831
2026-01-20 4 FORM 4 0001684273-26-000001 4926
2026-01-20 4 FORM 4 0001832579-26-000001 4764
2025-12-23 144 xsl144X01/primary_doc.xml 0001959173-25-007907 001-39725 251599507 33 4300
2025-12-19 144 xsl144X01/primary_doc.xml 0001959173-25-007867 001-39725 251588092 33 4839
2025-12-09 4 FORM 4 0001251299-25-000004 7725
2025-11-18 4 FORM 4 0001684273-25-000004 5095
2025-11-17 4 FORM 4 0001380632-25-000006 5820
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001398344-25-020925 005-92094 251481844 34 15831
2025-11-13 4 FORM 4 0001380632-25-000004 7877
2025-11-07 10-Q 10-Q 0001823239-25-000120 001-39725 251462967 34 9475548 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001823239-25-000117 001-39725 251458116 34 391683 1 1
2025-10-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000251 005-92094 251438819 34 6299
2025-10-27 8-K 8-K 5.02 0001823239-25-000113 001-39725 251420166 34 146698 1 1
2025-10-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-002607 005-92094 251401837 34 10924
2025-08-11 10-Q 10-Q 0001823239-25-000107 001-39725 251202840 34 9434905 1 1
2025-08-11 8-K 8-K 2.02,2.05,5.02,9.01 0001823239-25-000105 001-39725 251202033 34 395937 1 1
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000955 005-92094 251160257 34 6232
2025-07-18 8-K 8-K 4.01,9.01 0001823239-25-000099 001-39725 251134986 34 157825 1 1
2025-07-16 4 FORM 4 0001823239-25-000097 4821
2025-07-11 4 FORM 4 0001823239-25-000095 6828
2025-06-30 4 FORM 4 0001823239-25-000093 10539
2025-06-30 3 FORM 3 0001823239-25-000092 488280
2025-06-25 8-K 8-K 5.02,7.01,9.01 0001193125-25-146905 001-39725 251073771 34 451754 1 1
2025-06-18 4 FORM 4 0001823239-25-000089 5433
2025-06-18 4 FORM 4 0001823239-25-000088 4885
2025-06-18 4 FORM 4 0001823239-25-000087 5417
2025-06-18 4 FORM 4 0001823239-25-000086 5639
2025-06-18 4 FORM 4 0001823239-25-000085 4895
2025-06-18 4 FORM 4 0001823239-25-000084 5433
2025-06-18 4 FORM 4 0001823239-25-000083 5042
2025-06-18 4 FORM 4 0001823239-25-000082 5487
2025-06-18 4 FORM 4 0001823239-25-000081 4915
2025-06-18 4 FORM 4 0001823239-25-000080 4898
2025-06-10 4 4 0000950170-25-084483 10462
2025-06-10 3 3 0000950170-25-084477 20781
2025-06-09 8-K 8-K 5.02,7.01,9.01 0001193125-25-137478 001-39725 251032918 34 467819 1 1
2025-05-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001398344-25-010597 005-92094 251004885 34 24493
2025-05-28 4 FORM 4 0001823239-25-000069 5091
2025-05-28 4 FORM 4 0001823239-25-000068 5161
2025-05-28 8-K 8-K 5.07 0001823239-25-000065 001-39725 25996630 34 157296 1 1
2025-05-12 S-8 S-8 0001193125-25-117900 333-287199 25935984 33 222015 1 1
2025-05-12 10-Q 10-Q 0001823239-25-000063 001-39725 25935277 34 7418280 1 1
2025-05-12 8-K 8-K 2.02,9.01 0001823239-25-000062 001-39725 25934845 34 323796 1 1
2025-04-18 ARS ARS 0001193125-25-085767 001-39725 25850518 34 12010457
2025-04-18 DEF 14A DEF 14A 0001193125-25-085761 001-39725 25850490 34 3935501 1 1
2025-03-20 8-K 8-K 7.01 0001823239-25-000059 001-39725 25756976 34 162516 1 1
2025-03-19 4 FORM 4 0001823239-25-000056 5081
2025-03-19 4 FORM 4 0001823239-25-000055 4986
2025-03-19 4 FORM 4 0001823239-25-000054 5103
2025-03-19 4 FORM 4 0001823239-25-000053 5043
2025-03-19 4 FORM 4 0001823239-25-000052 5111
2025-03-19 4 FORM 4 0001823239-25-000051 5146
2025-03-19 4 FORM 4 0001823239-25-000044 4865
2025-03-19 4 FORM 4 0001823239-25-000043 4827
2025-03-19 4 FORM 4 0001823239-25-000042 4770
2025-03-19 4 FORM 4 0001823239-25-000041 4930
2025-03-19 4 FORM 4 0001823239-25-000040 4887
2025-03-18 10-K 10-K 0001823239-25-000034 001-39725 25748361 34 22209726 1 1
2025-03-18 8-K 8-K 2.02,4.02,9.01 0001823239-25-000033 001-39725 25748323 34 406922 1 1
2025-03-04 NT 10-K NT 10-K 0001823239-25-000030 001-39725 25705888 34 40462
2025-02-25 8-K 8-K 2.02,7.01,9.01 0001823239-25-000028 001-39725 25658964 34 175247 1 1
2025-02-20 UPLOAD filename1.pdf 0000000000-25-001972 001-39725 39709
2025-02-19 CORRESP filename1.htm 0001823239-25-000026 18001
2025-02-19 4 FORM 4 0001823239-25-000024 4770
2025-02-19 4 FORM 4 0001823239-25-000023 4930
2025-02-19 4 FORM 4 0001823239-25-000022 4865
2025-01-31 4 FORM 4 0001823239-25-000018 4732
2025-01-31 144 xsl144X01/primary_doc.xml 0001959173-25-000562 001-39725 25576255 33 8616
2025-01-28 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000500 005-92094 25561989 34 10787
2025-01-17 4 FORM 4 0001823239-25-000016 4896
2025-01-17 4 FORM 4 0001823239-25-000015 4866
2025-01-17 4 FORM 4 0001823239-25-000014 4899
2025-01-17 4 FORM 4 0001823239-25-000013 4888
2025-01-17 4 FORM 4 0001823239-25-000012 4771
2025-01-17 4 FORM 4 0001823239-25-000011 4933
2025-01-17 4 FORM 4 0001823239-25-000010 4828
2025-01-08 8-K 8-K 2.02,5.02 0001823239-25-000002 001-39725 25518674 34 175007 1 1
2024-12-18 8-K 8-K 8.01 0001823239-24-000133 001-39725 241559773 34 153617 1 1
2024-12-17 4 FORM 4 0001823239-24-000130 5100
2024-12-09 4 FORM 4 0001823239-24-000128 6834
2024-12-05 3 FORM 3 0001823239-24-000126 494783
2024-12-05 8-K 8-K 5.02,7.01 0001823239-24-000124 001-39725 241529147 34 290996 1 1
2024-11-18 4 FORM 4 0001823239-24-000122 4888
2024-11-14 SC 13G/A MARAVAI LIFESCIENCES HOLDINGS, INC. 0000902664-24-006646 005-92094 241465297 34 76513
2024-11-14 4 FORM 4 0001823239-24-000120 5072
2024-11-13 SC 13G/A SC 13G/A 0001193125-24-257312 005-92094 241455211 34 139532
2024-11-13 SC 13G/A MARAVAI LIFESCIENCES HOLDINGS, INC. 0000902664-24-006453 005-92094 241451545 34 62410
2024-11-12 10-Q 10-Q 0001823239-24-000118 001-39725 241450005 34 8543071 1 1
2024-11-12 4 FORM 4 0001823239-24-000117 5102
2024-11-12 4 FORM 4 0001823239-24-000115 5004
2024-11-12 4 FORM 4 0001823239-24-000114 5063
2024-11-12 4 FORM 4 0001823239-24-000113 6535
2024-11-12 4 FORM 4 0001823239-24-000112 5128
2024-11-08 SC 13G us56600d1072_110824.txt 0002012383-24-003478 005-92094 241439625 34 14013
2024-11-07 8-K 8-K 2.02,9.01 0001823239-24-000105 001-39725 241435471 34 401268 1 1
2024-10-29 SC 13G/A MRVI_SC13GA1_Oct2024.htm 0001273087-24-000108 005-92094 241406038 34 81859
2024-10-22 SC 13G us56600d1072_102224.txt 0002012383-24-001290 005-92094 241386106 34 13999
2024-10-16 4 FORM 4 0001823239-24-000102 4896
2024-09-17 UPLOAD filename1.pdf 0000000000-24-010517 001-39725 42871
2024-09-12 8-K 8-K 1.01,9.01 0001823239-24-000100 001-39725 241294894 34 84263260 1 1
2024-08-16 CORRESP filename1.htm 0001823239-24-000097 49891
2024-08-08 10-Q 10-Q 0001823239-24-000095 001-39725 241188240 34 7297381 1 1
2024-08-07 8-K 8-K 2.02,9.01 0001823239-24-000093 001-39725 241183651 34 390051 1 1
2024-07-29 8-K 8-K 5.02,7.01 0001823239-24-000091 001-39725 241152468 34 176403 1 1
2024-07-19 UPLOAD filename1.pdf 0000000000-24-008226 001-39725 44060
2024-07-16 4 FORM 4 0001823239-24-000089 4828
2024-06-24 CORRESP filename1.htm 0001823239-24-000087 67570
2024-06-12 UPLOAD filename1.pdf 0000000000-24-006768 001-39725 48167
2024-06-12 8-K 8-K 5.02 0001823239-24-000084 001-39725 241037032 34 152897 1 1
2024-06-10 SC 13G MARAVAI LIFESCIENCES HOLDINGS, INC. 0000902664-24-004156 005-92094 241033132 34 86290
2024-05-30 4 4 0000950170-24-066799 26308
2024-05-28 144 xsl144X01/primary_doc.xml 0000950170-24-065598 001-39725 24993783 33 4911
2024-05-28 144 xsl144X01/primary_doc.xml 0000950170-24-065597 001-39725 24993781 33 4908
2024-05-28 8-K 8-K 5.07 0001823239-24-000082 001-39725 24993069 34 165826 1 1
2024-05-24 4 FORM 4 0001823239-24-000080 5418
2024-05-24 4 FORM 4 0001823239-24-000079 5364
2024-05-24 4 FORM 4 0001823239-24-000078 4826
2024-05-24 4 FORM 4 0001823239-24-000077 4813
2024-05-24 4 FORM 4 0001823239-24-000076 5364
2024-05-24 4 FORM 4 0001823239-24-000075 4847
2024-05-24 4 FORM 4 0001823239-24-000074 5348
2024-05-24 4 FORM 4 0001823239-24-000073 4829
2024-05-24 4 FORM 4 0001823239-24-000072 4817
2024-05-24 4 FORM 4 0001823239-24-000071 4864
2024-05-14 SC 13G MRVI_SC13G_May2024.htm 0001273087-24-000070 005-92094 24944759 34 81799
2024-05-09 10-Q 10-Q 0001823239-24-000060 001-39725 24931490 34 6676617 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001823239-24-000058 001-39725 24926066 34 327352 1 1
2024-05-02 4 FORM 4 0001823239-24-000056 5003
2024-05-02 4 FORM 4 0001823239-24-000055 5101
2024-05-02 4 FORM 4 0001823239-24-000054 5127
2024-05-02 4 FORM 4 0001823239-24-000053 5165
2024-05-02 4 FORM 4 0001823239-24-000052 5063
2024-04-25 ARS ARS 0001193125-24-114072 001-39725 24877104 34 1965289
2024-04-25 DEF 14A DEF 14A 0001193125-24-114058 001-39725 24877075 34 6304188 1 1
2024-04-16 4 FORM 4 0001823239-24-000046 4892
2024-03-18 4 FORM 4 0001823239-24-000044 4887
2024-03-18 4 FORM 4 0001823239-24-000042 4770
2024-03-18 4 FORM 4 0001823239-24-000040 4932
2024-03-18 4 FORM 4 0001823239-24-000038 4827
2024-03-18 4 FORM 4 0001823239-24-000036 4865
2024-03-18 4 FORM 4 0001823239-24-000034 5512
2024-02-29 10-K 10-K 0001823239-24-000032 001-39725 24704928 34 23697533 1 1
2024-02-28 SC 13G/A MARAVAI LIFESCIENCES HOLDINGS, INC. 0000902664-24-002084 005-92094 24695557 34 68490
2024-02-22 8-K 8-K 2.02,9.01 0001823239-24-000028 001-39725 24664770 34 397190 1 1
2024-02-20 4 FORM 4 0001823239-24-000026 4770
2024-02-20 4 FORM 4 0001823239-24-000025 4865
2024-02-20 4 FORM 4 0001823239-24-000024 4932
2024-02-20 4 FORM 4 0001823239-24-000023 5512
2024-02-14 SC 13G MRVI13G2023.txt 0001540531-24-000007 005-92094 24642413 34 8589
2024-02-14 SC 13G MRVI13G2023.txt 0001540531-24-000008 005-92094 24640951 34 8589
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021404 005-92094 24628884 34 13117
2024-02-08 SC 13G/A SC 13G/A 0001193125-24-028432 005-92094 24609794 34 148286
2024-01-18 4 FORM 4 0001823239-24-000018 5105
2024-01-18 4 FORM 4 0001823239-24-000016 5109
2024-01-18 4 FORM 4 0001823239-24-000014 5041
2024-01-18 4 FORM 4 0001823239-24-000012 4984
2024-01-18 4 FORM 4 0001823239-24-000010 5079
2024-01-18 4 FORM 4 0001823239-24-000008 5724
2024-01-18 4 FORM 4 0001823239-24-000006 5146
2024-01-18 4 FORM 4 0001823239-24-000004 5101
2024-01-18 5 FORM 5 0001823239-24-000002 7780
2024-01-05 SC 13G/A MRVI_SC13GA1.htm 0001273087-24-000003 005-92094 24516354 34 81841
2023-11-16 4 FORM 4 0001823239-23-000097 4979
2023-11-16 4 FORM 4 0001823239-23-000096 5019
2023-11-16 4 FORM 4 0001823239-23-000095 5068
2023-11-16 4 FORM 4 0001823239-23-000094 4805
2023-11-08 10-Q 10-Q 0001823239-23-000089 001-39725 231389358 34 10034836 1 1
2023-11-07 8-K 8-K 2.02,9.01 0001823239-23-000087 001-39725 231383914 34 390466 1 1
2023-11-07 SC 13G/A SEC SCHEDULE 13G 0000912938-23-000488 005-92094 231382336 34 17548
2023-10-26 SC 13G MRVI_SC13G.htm 0001273087-23-000144 005-92094 231350516 34 81723
2023-10-17 4 FORM 4 0001823239-23-000085 4814
2023-08-22 4 FORM 4 0001823239-23-000083 6166
2023-08-08 10-Q 10-Q 0001823239-23-000081 001-39725 231151693 34 9881169 1 1
2023-08-07 8-K 8-K 2.02,9.01 0001823239-23-000079 001-39725 231147880 34 383599 1 1
2023-07-27 8-K 8-K 5.02,7.01,9.01 0001823239-23-000077 001-39725 231118520 34 204973 1 1
2023-07-21 4 FORM 4 0001823239-23-000075 5036
2023-07-20 3 FORM 3 0001823239-23-000073 457499
2023-07-20 8-K 8-K 5.02,7.01 0001823239-23-000072 001-39725 231099815 34 180232 1 1
2023-07-19 4 FORM 4 0001823239-23-000068 5058
2023-07-19 4 FORM 4 0001823239-23-000067 4966
2023-07-19 4 FORM 4 0001823239-23-000066 5110
2023-07-19 4 FORM 4 0001823239-23-000065 4845
2023-07-19 4 FORM 4 0001823239-23-000064 6634
2023-07-19 4 FORM 4 0001823239-23-000063 5363
2023-07-19 4 FORM 4 0001823239-23-000062 4825
2023-07-19 4 FORM 4 0001823239-23-000061 4812
2023-07-19 4 FORM 4 0001823239-23-000060 4863
2023-07-19 4 FORM 4 0001823239-23-000059 4816
2023-07-19 4 FORM 4 0001823239-23-000058 5417
2023-07-19 4 FORM 4 0001823239-23-000057 5347
2023-07-19 4 FORM 4 0001823239-23-000056 5363
2023-05-22 8-K 8-K 5.07 0001823239-23-000041 001-39725 23944371 34 188571 1 1
2023-05-09 10-Q 10-Q 0001823239-23-000039 001-39725 23903291 34 9935488 1 1
2023-05-08 8-K 8-K 2.02,9.01 0001823239-23-000037 001-39725 23897804 34 337350 1 1
2023-04-20 ARS ARS 0001193125-23-108455 001-39725 23833879 34 6342218
2023-04-20 DEF 14A DEF 14A 0001193125-23-108444 001-39725 23833852 34 4448149 1 1
2023-04-06 3 FORM 3 0001823239-23-000034 462686
2023-04-06 3 FORM 3 0001823239-23-000033 457860
2023-03-17 4 FORM 4 0001823239-23-000030 7334
2023-03-17 4 FORM 4 0001823239-23-000029 7395
2023-03-17 4 FORM 4 0001823239-23-000028 7432
2023-03-17 4 FORM 4 0001823239-23-000027 7482
2023-03-17 4 FORM 4 0001823239-23-000026 8074
2023-03-13 8-K 8-K 5.02 0001823239-23-000020 001-39725 23727322 34 176464 1 1
2023-03-10 8-K 8-K 7.01 0001823239-23-000017 001-39725 23723668 34 176226 1 1
2023-02-28 10-K 10-K 0001823239-23-000014 001-39725 23685385 34 23506232 1 1
2023-02-22 8-K 8-K 2.02,9.01 0001823239-23-000012 001-39725 23653242 34 414655 1 1
2023-02-17 4 FORM 4 0001823239-23-000010 4841
2023-02-17 4 FORM 4 0001823239-23-000009 4772
2023-02-17 4 FORM 4 0001823239-23-000008 5432
2023-02-17 4 FORM 4 0001823239-23-000007 4792
2023-02-17 4 FORM 4 0001823239-23-000006 4697
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #3 0000899140-23-000323 005-92094 23621287 34 69442
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016417 005-92094 23603695 34 13033
2023-02-08 SC 13G/A SEC SCHEDULE 13G 0000912938-23-000191 005-92094 23599147 34 17553
2023-01-24 4 FORM 4 SUBMISSION 0000899243-23-002476 16624
2022-12-01 8-K 8-K 5.02,7.01,9.01 0001193125-22-296553 001-39725 221439097 34 163394 1 1
2022-11-10 SC 13G/A SCHEDULE 13G/A, AMENDMENT #2 0000899140-22-000788 005-92094 221378009 34 66417
2022-11-09 4 FORM 4 0001823239-22-000064 4958
2022-11-09 4 FORM 4 0001823239-22-000063 5026
2022-11-09 4 FORM 4 0001823239-22-000062 4931
2022-11-04 10-Q 10-Q 0001823239-22-000058 001-39725 221359560 34 10750387 1 1
2022-11-02 8-K 8-K 2.02,9.01 0001823239-22-000056 001-39725 221354090 34 402091 1 1
2022-10-19 4 FORM 4 SUBMISSION 0000899243-22-033827 12930
2022-10-19 8-K 8-K 5.02,7.01,9.01 0001823239-22-000052 001-39725 221318688 34 194637 1 1
2022-10-05 3 FORM 3 0001823239-22-000049 459806
2022-10-03 8-K 8-K 5.02,7.01,9.01 0001823239-22-000048 001-39725 221287567 34 577769 1 1
2022-09-06 SC 13G/A SEC SCHEDULE 13G 0000912938-22-000435 005-92094 221228237 34 17612
2022-09-06 SC 13G/A SEC SCHEDULE 13G 0000912938-22-000437 005-92094 221228016 34 17612
2022-08-05 10-Q 10-Q 0001823239-22-000044 001-39725 221140954 34 10444163 1 1
2022-08-04 8-K 8-K 2.02,9.01 0001823239-22-000042 001-39725 221136514 34 399428 1 1
2022-07-28 UPLOAD filename1.pdf 0000000000-22-007922 39552
2022-07-19 4 FORM 4 0001823239-22-000040 7358
2022-07-12 CORRESP filename1.htm 0001823239-22-000038 61208
2022-07-11 SC 13G/A filing.txt 0000315066-22-001659 005-92094 221075953 34 8177
2022-06-29 UPLOAD filename1.pdf 0000000000-22-006949 45364
2022-06-28 3 FORM 3 0001823239-22-000036 503009
2022-06-27 4/A FORM 4/A 0001823239-22-000034 5057
2022-06-27 4/A FORM 4/A 0001823239-22-000033 5136
2022-06-27 4/A FORM 4/A 0001823239-22-000032 5155
2022-06-27 4 FORM 4 0001823239-22-000028 4825
2022-06-27 4 FORM 4 0001823239-22-000027 5075
2022-06-27 4 FORM 4 0001823239-22-000026 4920
2022-06-27 4 FORM 4 0001823239-22-000025 4900
2022-05-16 8-K 8-K 5.07 0001823239-22-000020 001-39725 22929926 34 191161 1 1
2022-05-06 10-Q 10-Q 0001823239-22-000018 001-39725 22902120 34 8457328 1 1
2022-05-05 8-K 8-K 2.02,9.01 0001823239-22-000015 001-39725 22896282 34 331679 1 1
2022-04-14 DEF 14A DEF 14A 0001193125-22-105524 001-39725 22827176 34 819053
2022-03-01 10-K 10-K 0001823239-22-000012 001-39725 22697955 34 16530103 1 1
2022-02-23 8-K 8-K 2.02,9.01 0001823239-22-000008 001-39725 22663581 34 388876 1 1
2022-02-14 SC 13G/A MARAVAI LIFESCIENCES HOLDINGS, INC. 0000902664-22-001641 005-92094 22626612 34 63571
2022-02-14 SC 13G/A SCHEDULE 13G (AMENDMENT NO. 3) 0000899140-22-000237 005-92094 22623072 34 66969
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-037070 005-92094 22621186 34 151174
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018035 005-92094 22610275 34 13028
2022-02-09 SC 13G/A filing.txt 0000315066-22-001102 005-92094 22604403 34 8591
2022-02-02 SC 13G SEC SCHEDULE 13G 0000912938-22-000206 005-92094 22582435 34 17596
2022-02-01 4 FORM 4 SUBMISSION 0000899243-22-003853 7585
2022-01-28 8-K 8-K 7.01,9.01 0001823239-22-000006 001-39725 22565369 34 198760 1 1
2022-01-27 4 FORM 4 SUBMISSION 0000899243-22-003418 11186
2022-01-27 4 FORM 4 SUBMISSION 0000899243-22-003417 11166
2022-01-27 4 FORM 4 SUBMISSION 0000899243-22-003416 11095
2022-01-27 4 FORM 4 SUBMISSION 0000899243-22-003415 8358
2022-01-27 4 FORM 4 SUBMISSION 0000899243-22-003414 11239
2022-01-20 8-K 8-K 1.01,9.01 0001823239-22-000004 001-39725 22542425 34 85504100 1 1
2022-01-04 4 FORM 4 SUBMISSION 0000899243-22-000472 22862
2022-01-03 8-K 8-K 8.01,9.01 0001823239-22-000002 001-39725 22502131 34 181415 1 1
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045775 4721
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045774 4743
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045777 4710
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045773 4717
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045776 4745
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045770 4703
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045772 4691
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045768 4681
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045771 4760
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045767 4693
2021-11-15 10-Q 10-Q 0001823239-21-000028 001-39725 211405604 34 9467183 1 1
2021-11-10 8-K 8-K 2.02,9.01 0001823239-21-000025 001-39725 211396634 34 404651 1 1
2021-11-09 SC 13G SCHEDULE 13G 0000899140-21-000717 005-92094 211393168 34 66982
2021-09-13 4 FORM 4 SUBMISSION 0000899243-21-035674 24539
2021-09-13 424B4 424B4 0001193125-21-271450 333-259366 211249868 33 413817
2021-09-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-09-09 16:00:00 9999999995-21-003472 333-259366 211245764 33 1720
2021-09-07 CORRESP filename1.htm 0001193125-21-266689 11947
2021-09-07 CORRESP filename1.htm 0001193125-21-266683 8723
2021-09-07 S-1 S-1 0001193125-21-266593 333-259366 211239366 33 751157
2021-09-03 8-K 8-K 1.01,2.01,9.01 0001823239-21-000023 001-39725 211236495 34 262342 1 1
2021-08-31 UPLOAD filename1.pdf 0000000000-21-010613 40539
2021-08-26 DRS filename1.htm 0000950123-21-011884 377-05418 211212995 33 520963
2021-08-11 10-Q 10-Q 0001823239-21-000021 001-39725 211164302 34 9811625 1 1
2021-08-10 8-K 8-K 1.01,2.02,9.01 0001823239-21-000018 001-39725 211160155 34 1388034 1 1
2021-05-20 8-K 8-K 5.02,5.07 0001823239-21-000016 001-39725 21944607 34 38347
2021-05-12 10-Q 10-Q 0001823239-21-000013 001-39725 21915490 34 7241137 1 1
2021-05-10 8-K 8-K 2.02,9.01 0001823239-21-000011 001-39725 21907525 34 144743
2021-04-19 DEF 14A DEF 14A 0001193125-21-121346 001-39725 21835138 34 519724
2021-04-12 SC 13G/A filing.txt 0000315066-21-001478 005-92094 21820102 34 8541
2021-04-09 4 FORM 4 SUBMISSION 0000899243-21-015484 31429
2021-04-09 PRE 14A PRE 14A 0001193125-21-111589 001-39725 21818028 34 452887
2021-04-09 424B4 424B4 0001193125-21-111541 333-255043 21817814 33 913488
2021-04-07 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-04-07 16:00:00 9999999995-21-001335 333-255043 21813656 33 1719
2021-04-07 S-1MEF S-1MEF 0001193125-21-109166 333-255115 21813536 33 43752
2021-04-06 S-1/A S-1/A 0001193125-21-107740 333-255043 21809881 33 306915
2021-04-05 CORRESP filename1.htm 0001193125-21-106522 10497
2021-04-05 CORRESP filename1.htm 0001193125-21-106517 6339
2021-04-05 8-K 8-K 2.02,8.01,9.01 0001823239-21-000009 001-39725 21806539 34 59834
2021-04-05 S-1 S-1 0001193125-21-106471 333-255043 21806440 33 1008748
2021-04-01 UPLOAD filename1.pdf 0000000000-21-003907 40506
2021-03-25 DRS filename1.htm 0000950123-21-003859 377-04505 21769905 33 990642
2021-03-22 10-K 10-K 0001823239-21-000006 001-39725 21761565 34 7347707
2021-03-02 8-K 8-K 2.02,9.01 0001823239-21-000003 001-39725 21703852 34 168037
2021-02-16 SC 13G SCHEDULE 13G 0000950142-21-000601 005-92094 21633474 34 58547
2021-02-11 SC 13G SC 13G 0001193125-21-038384 005-92094 21619482 34 173486
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-018575 005-92094 21611348 34 13867
2021-02-08 SC 13G filing.txt 0000315066-21-001131 005-92094 21599683 34 8535
2020-11-30 4 FORM 4 SUBMISSION 0000899243-20-032306 5241
2020-11-27 4 FORM 4 SUBMISSION 0000899243-20-032274 24533
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032223 4514
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032221 4606
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032220 4509
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032218 4523
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032217 4561
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032216 4543
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032215 4528
2020-11-25 8-K 8-K 1.01,3.02,3.03,5.02,5.03,8.01,9.01 0001193125-20-303088 001-39725 201346870 34 1425303
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031956 5735
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031955 5666
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031954 4560
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031952 5591
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031948 5618
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031947 5686
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031946 4542
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031942 5666
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031940 4522
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031939 5758
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031938 4500
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031935 4513
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031934 4508
2020-11-23 3 FORM 3 SUBMISSION 0000899243-20-031929 7547
2020-11-23 S-8 S-8 0001193125-20-301489 333-250895 201338748 33 329497
2020-11-23 424B4 424B4 0001193125-20-301431 333-249733 201338144 33 6282608
2020-11-20 3 FORM 3 SUBMISSION 0000899243-20-031839 29070
2020-11-19 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-11-19 16:00:00 9999999995-20-003244 333-249733 201330385 33 1720
2020-11-19 3 FORM 3 SUBMISSION 0000899243-20-031728 7641
2020-11-19 3 FORM 3 SUBMISSION 0000899243-20-031727 7607
2020-11-19 3 FORM 3 SUBMISSION 0000899243-20-031726 7638
2020-11-19 3 FORM 3 SUBMISSION 0000899243-20-031724 7529
2020-11-19 3 FORM 3 SUBMISSION 0000899243-20-031722 7579
2020-11-19 3 FORM 3 SUBMISSION 0000899243-20-031721 7548
2020-11-19 3 FORM 3 SUBMISSION 0000899243-20-031717 7418
2020-11-19 3 FORM 3 SUBMISSION 0000899243-20-031714 7585
2020-11-19 3 FORM 3 SUBMISSION 0000899243-20-031713 7514
2020-11-19 3 FORM 3 SUBMISSION 0000899243-20-031712 7571

Latest XBRL company facts

One latest value per concept from companyfacts (352 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 300.00M 2025-06-30 2025 FY 10-K 2026-02-26 0001823239-26-000011
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 185.70M 2025-01-01 2025-12-31 DEFA14A 2026-04-28 0001823239-26-000016
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.98M 2025-01-01 2025-12-31 DEFA14A 2026-04-28 0001823239-26-000016
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.00M 2025-01-01 2025-12-31 DEFA14A 2026-04-28 0001823239-26-000016
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 130.77 2025-01-01 2025-12-31 DEFA14A 2026-04-28 0001823239-26-000016
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 10.89 2025-01-01 2025-12-31 DEFA14A 2026-04-28 0001823239-26-000016
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 6.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 25.71M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 1.45M 2021-06-30 2021 Q2 10-Q 2021-08-11 0001823239-21-000021
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 25.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.73M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 68.08M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 456,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 212.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AdjustmentForAmortization Amortization USD 19.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 27.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AdvertisingExpense Advertising Expense USD 4.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 27.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 800,000 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 1.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 19.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 138.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 2.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap Assets Assets USD 600.07M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AssetsCurrent Assets, Current USD 154.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 323.36M 2024-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 125.03M 2021-06-30 2021 Q2 10-Q 2021-08-11 0001823239-21-000021
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 1.27M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 4.94M 2025-06-30 2025 Q2 10-Q 2025-08-11 0001823239-25-000107
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 4.94M 2025-06-30 2025 Q2 10-Q 2025-08-11 0001823239-25-000107
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap BusinessCombinationIntegrationRelatedCosts Business Combination, Integration Related Costs USD 761,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 198,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 1.17M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 56.17M 2020-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 4.65M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 5.07M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 5.11M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 5.01M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 25.25M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1 Capital Leases, Future Minimum Payments, Net Minimum Payments USD 45.18M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments USD 19.93M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear Capital Leases, Future Minimum Payments, Remainder of Fiscal Year USD 1.07M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap CapitalLeasesIncomeStatementAmortizationExpense Capital Leases, Income Statement, Amortization Expense USD 2.08M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap Cash Cash USD 628.27M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001823239-23-000039
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 73.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 72.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 73.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -143.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001823239-25-000120
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -30.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -22.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -52.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ConstructionPayableCurrent Construction Payable, Current USD 21.74M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001823239-23-000039
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 0 2026-03-31 2026 Q1 10-Q 2026-05-08 0001823239-26-000024
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 0 2025-09-30 2025 Q3 10-Q 2025-11-07 0001823239-25-000120
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 4.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 1.99M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap CostOfRevenue Cost of Revenue USD 92.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap CostsAndExpenses Costs and Expenses USD 108.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -3.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 105,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -4.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -1.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 1.30M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001823239-26-000024
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 2.82M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -20,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 0 2023-12-31 2023 FY 10-K 2024-02-29 0001823239-24-000032
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -20,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.29M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 2.03M 2025-06-30 2025 Q2 10-Q 2025-08-11 0001823239-25-000107
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 3.34M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 741.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 558.38M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 808.12M 2021-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 54,000 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 156.31M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 373,000 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 3.12M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 6.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 740.95M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 2.23M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 2.29M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 2.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap Depreciation Depreciation USD 15.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap DerivativeAssets Derivative Asset USD 1.38M 2024-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap DerivativeAssetsCurrent Derivative Asset, Current USD 0 2025-03-31 2025 Q1 10-Q 2025-05-12 0001823239-25-000063
us-gaap DerivativeAssetsNoncurrent Derivative Asset, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 42.25M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001823239-23-000039
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 719.60M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001823239-23-000039
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 677.39M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001823239-23-000039
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.008 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.121 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent pure 0.092 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001823239-24-000032
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.01 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 57,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-04 0001823239-22-000058
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 11.11M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 4.50M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 2.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 2.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 31.11M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 966,000 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 29.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 51.27M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 32.53M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 3.53M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 3.97M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 3.86M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 3.75M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 3.64M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 824,000 2023-09-30 2023 Q3 10-Q 2023-11-08 0001823239-23-000089
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 20.16M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 791,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 64.74M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization Finance Lease, Right-of-Use Asset, before Accumulated Amortization USD 78.60M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.084 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 184.28M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 34.45M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 25.66M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 7.21M 2025-09-30 2025 Q3 10-Q 2025-11-07 0001823239-25-000120
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 19.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 23.31M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 24.47M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 24.65M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 363.64M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 151.54M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001823239-24-000032
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -3.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap Goodwill Goodwill USD 129.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 12.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 25.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD 228,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap GoodwillTransfers Goodwill, Transfers USD 130.90M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap GovernmentAssistanceAmountCumulativeCurrent GovernmentAssistanceAmountCumulativeCurrent USD 608,000 2024-06-30 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap GrossProfit Gross Profit USD 70.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001823239-25-000120
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -224.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -52.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -10.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap IncomeTaxesPaid Income Taxes Paid USD 23.03M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -397,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 28.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -49.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -1.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -2.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 4.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 190,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -8.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -735,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-11 0001823239-25-000107
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 2.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 2.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -181,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 130.97M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap InterestExpense Interest Expense USD 36.44M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001823239-24-000118
us-gaap InterestExpenseLesseeAssetsUnderCapitalLease Interest Expense, Lessee, Assets under Capital Lease USD 162,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001823239-21-000021
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 14.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 17.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap InterestPayableCurrent Interest Payable, Current USD 4.04M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 19.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap InventoryNet Inventory, Net USD 43.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 13.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 10.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 3.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 3.20M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap LeaseCost Lease, Cost USD 24.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 82.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 42.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 6.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 8.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 5.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 9.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 9.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 33.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap Liabilities Liabilities USD 259.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 600.07M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LiabilitiesCurrent Liabilities, Current USD 33.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 11.49M 2021-06-30 2021 Q2 10-Q 2021-08-11 0001823239-21-000021
us-gaap LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation Limited Liability Company (LLC) Members' Equity, Unit-based Payment Arrangement USD 3.28M 2020-01-01 2020-11-19 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap LongTermDebt Long-term Debt USD 147.18M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 142.13M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 375,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 145.68M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ManagementFeeExpense Management Fee Expense USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap MembersEquity Members' Equity USD 144.63M 2019-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsRemainderOfFiscalYear Minimum Lease Payments, Sale Leaseback Transactions, Remainder of Fiscal Year USD 1.20M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001823239-21-000013
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsWithinOneYear Minimum Lease Payments, Sale Leaseback Transactions, Next Twelve Months USD 1.80M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001823239-21-000013
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 144.28M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders USD 572,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-07 0001823239-25-000120
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 166.43M 2020-01-01 2020-11-19 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap MinorityInterestPeriodIncreaseDecrease Noncontrolling Interest, Period Increase (Decrease) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap NetCashProvidedByUsedInDiscontinuedOperations Net Cash Provided by (Used in) Discontinued Operations USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-05 0001823239-22-000044
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -155.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -5.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 17.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -29.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -22.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -29.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -29.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001823239-26-000059
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001823239-24-000032
us-gaap NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap NumberOfReportingUnits Number of Reporting Units reporting_unit 3 2025-04-01 2025-06-30 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -37.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OperatingLeaseCost Operating Lease, Cost USD 8.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 49.42M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 48.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OperatingLeasePayments Operating Lease, Payments USD 8.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 48.26M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 4.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 14.94M 2020-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.78M 2020-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.10M 2020-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.37M 2020-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.34M 2020-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 3.06M 2020-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 5.29M 2020-12-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 117,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 2.10M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.104 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.89M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap OtherAdjustmentsToIncomeDiscontinuedOperations Other Adjustments to Income, Discontinued Operations USD -3.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 2.62M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -119,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -119,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 51.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -252,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 3,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001823239-21-000013
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -171,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap PaymentsForRepurchaseOfRedeemableNoncontrollingInterest Payments for Repurchase of Redeemable Noncontrolling Interest USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 3.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap PaymentsOfDividendsMinorityInterest Payments of Ordinary Dividends, Noncontrolling Interest USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001823239-25-000120
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001823239-25-000120
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 5.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 9.61M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001823239-23-000089
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2020-11-30 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2020-11-30 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 12.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ProceedsFromDerivativeInstrumentFinancingActivities Proceeds from Derivative Instrument, Financing Activities USD 1.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 150.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD -699,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ProceedsFromSaleOfBuildings Proceeds from Sale of Buildings USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001823239-24-000032
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 331,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001823239-23-000089
us-gaap ProfessionalFees Professional Fees USD 1.08M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -52.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization USD 135.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 151.48M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology Related Party Tax Expense Effect of Change in Allocation Methodology USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 50.00M 2020-11-01 2020-11-30 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 201,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 294.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 10.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap RestrictedCash Restricted Cash USD 489,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap RestructuringCharges Restructuring Charges USD 5.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap RestructuringCosts Restructuring Costs USD 5.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 5.34M 2025-09-30 2025 Q3 10-Q 2025-11-07 0001823239-25-000120
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -19.87M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 163.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 14.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap SaleAndLeasebackTransactionGainLossNet Sale and Leaseback Transaction, Gain (Loss), Net USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap SaleLeasebackTransactionCurrentPeriodGainRecognized Sale Leaseback Transaction, Current Period Gain Recognized USD 19.00M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap SaleLeasebackTransactionDeferredGainGross Sale Leaseback Transaction, Deferred Gain, Gross USD 3.10M 2020-03-31 2021 Q3 10-Q 2021-11-15 0001823239-21-000028
us-gaap SaleLeasebackTransactionGrossProceedsInvestingActivities Sale Leaseback Transaction, Gross Proceeds, Investing Activities USD 34.50M 2020-01-01 2020-01-31 2021 FY 10-K 2022-03-01 0001823239-22-000012
us-gaap SalesAndExciseTaxPayableCurrent Sales and Excise Tax Payable, Current USD 742,000 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 91.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 27.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 1.46M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 27,000 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.27M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 20.71 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.53M 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 12.91 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 5.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 20.79 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.45 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 195.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 340.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 1,000 2020-11-01 2020-11-30 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD -7.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 33.66M 2020-11-20 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 9.14M 2020-01-01 2020-11-19 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 1.06M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 0 2022-12-31 2022 FY 10-K 2023-02-28 0001823239-23-000014
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 1.92M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001823239-24-000060
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 1.87M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 262,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 218,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense Unrecognized Tax Benefits, Interest on Income Taxes Expense USD 300,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 3.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary Unrecorded Unconditional Purchase Obligation, to be Paid, Year One USD 619,000 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two USD 366,000 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three USD 4,000 2024-12-31 2024 FY 10-K 2025-03-18 0001823239-25-000034
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount Unrecorded Unconditional Purchase Obligation USD 4.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths Unrecorded Unconditional Purchase Obligation, Due in Next Rolling Twelve Months USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 1.23M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001823239-24-000118
us-gaap UnrecordedUnconditionalPurchaseObligationPurchases Unrecorded Unconditional Purchase Obligation, Purchases USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 47.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001823239-26-000011
us-gaap VariableLeaseCost Variable Lease, Cost USD 3.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 147.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 147.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001823239-26-000068

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →